Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-038789

Director sold 20,000 shares at an average $73.93 ($1,478,522)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-06-22 Sale −10,000 $72.51 $725,069 584,190 I: show line 1 in the form
Bolzon Bradley J PhD Director 2020-06-23 Sale −10,000 $75.35 $753,453 574,190 I: show line 2 in the form
Open-market sales · 20,000 sh · avg $73.93 · $1,478,522
Loading xslF345X03/doc4.xml…